Related Experiment Video
Updated: Apr 27, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Refining cerebrovascular risk in left atrial enlargement: integrating CKM framework and atrial cardiomyopathy
Weikai Dong1, Guangmin Yang1, Qiang Wang1
1Cardiovascular Medical Center, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, China.
Insights
Left atrial enlargement predicts short-term stroke risk in patients without atrial fibrillation. Further research should consider cardiovascular-kidney-metabolic interactions and atrial cardiomyopathy markers for improved risk prediction.
Area of Science:
- Cardiology
- Neurology
- Nephrology
Background:
- Left atrial enlargement is a known risk factor for cardiovascular events.
- Atrial fibrillation is a common cause of stroke, but risk in patients without it requires further investigation.
Abstract:
We critically appraise a large prospective cohort study on left atrial enlargement and 1-year cerebrovascular events in patients without atrial fibrillation. While the study provides valuable short-term prognostic evidence, we highlight four key considerations: the overlooked impact of cardiovascular-kidney-metabolic interaction, cautious interpretation of sex-specific findings due to lacking formal interaction tests, potential indication bias in antiplatelet protection claims, and the value of additional atrial cardiomyopathy markers beyond left atrial volume index. Addressing these aspects would enhance risk stratification and translational applicability.
More Related Videos
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

